Search

everythinglearnresearchcommunity

for

Search:↓

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Oxiconazole nitrate cream is effective and well-tolerated for treating various fungal skin infections.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Combining cyclosporine A and ketoconazole can effectively treat anal furunculosis in dogs, with some experiencing recurrences and mild side effects.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Stopping finasteride improved seizure control, suggesting neurosteroids affect seizures and treatment.